Categories: DNANews

Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Thursday, November 10, 2022, to discuss the company’s third quarter 2022 financial results and provide a business update.

The webcast of the conference call may be accessed by visiting “Events” at the investor relations section of the Wave Life Sciences corporate website: ir.wavelifesciences.com.

Participants planning to ask a question during the Q&A portion of the live call can join the webcast at the following audio conferencing link: https://register.vevent.com/register/BI3c61006b6de34cd6a3924918ba54e58f.

Following the conference call, an archived version of the call will be available on the website.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

Staff

Recent Posts

CareOregon and Health Share of Oregon Notify Members of Privacy Incident

PORTLAND, Ore., June 3, 2025 /PRNewswire/ -- CareOregon and Health Share of Oregon are notifying…

3 hours ago

CareOregon Notifies Members of Privacy Incident

PORTLAND, Ore., June 3, 2025 /PRNewswire/ -- CareOregon, Jackson Care Connect and Columbia Pacific CCO are…

3 hours ago

Tixel i® Demonstrates Sustained Improvements in Dry Eye Symptoms

Recent Publication Reports Durable Results and Patient Satisfaction KNOXVILLE, Tenn., June 3, 2025 /PRNewswire/ --…

9 hours ago

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

ST. PAUL, Minn., June 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will…

9 hours ago

BAILEY HOUSE ANNOUNCES THIRD ANNUAL ART HOUSE BENEFIT HONORING ARTIST DERRICK ADAMS

A CURATED ART AUCTION AND CELEBRATION OF ARTISTS IN SUPPORT OF HOUSING FOR NEW YORKERS…

9 hours ago

Net Health Acquires Limber Health

Investment Unites Two Leading Outcomes Platforms and Delivers Stronger Results for Enterprise Health Systems and…

9 hours ago